A potential merger between AstraZeneca and Bristol Myers Squibb would create one of the world's largest pharmaceutical groups, though regulators may oppose the deal due to competing cancer immunotherapies.

Researchers are validating urine-based liquid biopsy as a patient-friendly alternative to surgical tissue exams for detecting bladder, prostate, and kidney cancers.

A study published in Gut Microbes details how the bacterium Ewingella americana, isolated from Japanese tree frogs, achieved 100% tumor clearance in mice.

A study of 1,563 patients reveals that epigenetic regulation provides a more granular understanding of AML than traditional genetic sequencing alone. The findings correlate these subgroups with clinical outcomes and treatment responses.

Immunotherapy is shifting the survival landscape for patients with advanced cancers by training the immune system to target malignant cells. While these treatments have led to significant clinical breakthroughs, experts emphasize that sustainable research funding remains vital.